A detailed history of Achmea Investment Management B.V. transactions in Dexcom Inc stock. As of the latest transaction made, Achmea Investment Management B.V. holds 48,979 shares of DXCM stock, worth $3.93 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
48,979
Previous 17,905 173.55%
Holding current value
$3.93 Million
Previous $2.03 Million 61.72%
% of portfolio
0.05%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $1.99 Million - $3.61 Million
31,074 Added 173.55%
48,979 $3.28 Million
Q2 2024

Aug 08, 2024

BUY
$110.31 - $140.45 $1.19 Million - $1.51 Million
10,778 Added 151.23%
17,905 $2.03 Million
Q1 2024

May 08, 2024

SELL
$114.22 - $140.1 $909,990 - $1.12 Million
-7,967 Reduced 52.78%
7,127 $988,000
Q3 2023

Nov 06, 2023

SELL
$86.06 - $137.93 $92,772 - $148,688
-1,078 Reduced 6.67%
15,094 $1.41 Million
Q2 2023

Jul 24, 2023

BUY
$112.47 - $130.98 $468,325 - $545,400
4,164 Added 34.68%
16,172 $2.08 Million
Q1 2023

May 04, 2023

SELL
$104.0 - $122.92 $44,720 - $52,855
-430 Reduced 3.46%
12,008 $1.4 Million
Q4 2022

Feb 09, 2023

SELL
$84.98 - $122.67 $614,405 - $886,904
-7,230 Reduced 36.76%
12,438 $1.32 Million
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $1 Million - $1.96 Million
14,751 Added 300.0%
19,668 $1.47 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $144,805 - $194,295
-1,357 Reduced 21.63%
4,917 $2.69 Million
Q3 2020

Nov 02, 2020

BUY
$95.51 - $112.95 $599,229 - $708,648
6,274 New
6,274 $2.59 Million
Q1 2020

May 13, 2020

SELL
$47.79 - $75.63 $299,834 - $474,502
-6,274 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $169,335 - $234,459
6,274 New
6,274 $752,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Achmea Investment Management B.V. Portfolio

Follow Achmea Investment Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Achmea Investment Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Achmea Investment Management B.V. with notifications on news.